Evidence map›Paper›PMID 34402226›Full record

ArticleJournal of Korean medical science2021

Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.

Min Kyung Chung, Sung Soo Kim, Yun Hong Cheon, Seung Jae Hong, Hyo Jin Choi, Mi Ryoung Seo, Jiwon Hwang, Joong Kyong Ahn, Sang Heon Lee, Hong Ki Min and 14 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Korean medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Korean guidelines for the management of gout.The Korean journal of internal medicine · 2023
    Guideline
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Korean guidelines for the management of gout.Journal of rheumatic diseases · 2023
    Review
  10. Review
  11. Review
  12. Current state and prospects of gout treatment in Korea.The Korean journal of internal medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 1 country.

Min Kyung ChungDivision of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6414-9187
Sung Soo KimDivision of Rheumatology, Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.ORCID https://orcid.org/0000-0002-8556-343X
Yun Hong CheonDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.ORCID https://orcid.org/0000-0002-0099-6253
Seung Jae HongDivision of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Korea.ORCID https://orcid.org/0000-0002-9803-529X
Hyo Jin ChoiDivision of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.ORCID https://orcid.org/0000-0001-5192-6151
Mi Ryoung SeoDivision of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.ORCID https://orcid.org/0000-0002-5037-6087
Jiwon HwangDivision of Rheumatology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.ORCID https://orcid.org/0000-0003-4841-5400
Joong Kyong AhnDivision of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3246-4435
Sang Heon LeeDivision of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-7539-9330
Hong Ki MinDivision of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0003-1147-1046
Hoon Suk ChaDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5391-5376
Shin Seok LeeDivision of Rheumatology, Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0001-6810-7355
Jennifer LeeDivision of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-6873-6629
Ki Won MoonDivision of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.ORCID https://orcid.org/0000-0002-4182-8328
Chang Keun LeeDivision of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3653-7515
Hyun Ok KimDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.ORCID https://orcid.org/0000-0002-0904-1584
Young Sun SuhDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.ORCID https://orcid.org/0000-0002-5378-2590
Seung Cheol ShimDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0002-3199-359X
Seong Wook KangDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0002-0076-0822
Jinhyun KimDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0001-5235-2612
Sang Tae ChoiDivision of Rheumatology, Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2074-1733
Jung Soo SongDivision of Rheumatology, Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea. drsong@cau.ac.kr.ORCID https://orcid.org/0000-0001-8651-5125
Jisoo LeeDivision of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. leejisoo@ewha.ac.kr.ORCID https://orcid.org/0000-0001-6279-7025
Korean Society of Gout Research
Chungnam National University Hospital · KREwha Womans University · KRKonkuk University Medical Center · KRChung-Ang University · KRGachon University · KRGyeongsang National University · KRUlsan College · KRGyeongsang National University Hospital · KRKangbuk Samsung Hospital · KRKangwon National University · KRKyung Hee University · KRSamsung Medical Center · KRSamsung (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient-centered management is becoming increasingly important in gout, but there are limited studies exploring patients' perspectives and preferences. We aimed to investigate patients' perspectives and preferences regarding gout and gout management, and their impacts on adherence to urate lowering therapy (ULT).

methodsA paper-based survey was performed in patients with gout seen at the rheumatology outpatient clinics of 16 tertiary hospitals. The survey included questions regarding demographics, comorbidities, gout attacks, current treatment and adherence, and patients' perspectives and preferences regarding gout and gout management. Multivariate regression analysis was performed to determine the factors associated with ULT adherence.

resultsOf 809 surveyed patients with gout, 755 (94.5%) were using ULT. Among those using ULT, 89.1% had ≥ 80% adherence to ULT. Majority of the patients knew management strategies to some extent (94.8%), perceived gout as a life-long disease (91.2%), and were making efforts toward practicing at least one lifestyle modification (89.2%). Most patients (71.9%) obtained information about gout management during their clinic visits. Approximately half of the patients (53.6%) preferred managing their disease with both ULT and lifestyle modification, 28.4% preferred ULT only, and 17.4% preferred lifestyle modification only. Adherence was better in patients with older age (odds ratio [OR], 1.03), those with better knowledge of gout management strategies (OR, 3.56), and those who had preference for ULT (OR, 2.07).

conclusionPatients' perspectives and management preferences had high impacts on adherence to ULT in gout. Consideration of patients' perspectives and preferences is important for achieving the desired clinical outcome in gout.

Indexed as

Health Knowledge, Attitudes, PracticePatient PreferenceAdultAgedAged, 80 and overDisease ManagementFemaleGoutGout SuppressantsHealth Care SurveysHumansMaleMedication AdherenceMiddle AgedPatient-Centered CareSurveys and QuestionnairesGout SuppressantsDisease ManagementGoutPatient PreferencePerspective

Identifiers

PMID34402226
PMCPMC8369315
OpenAlexW3186175458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.